Modern upstream bioprocessing relies on tighter control strategies as regulators and manufacturers push toward real-time decision making. Yet the inherent variability of living cell systems makes it ...

The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this goal requires improved operational control and continuous real-time ...

Polyethylenimine (PEI)-assisted transfection is a mainstay in upstream processing (USP) for viral vector manufacturing. But recent developments are shifting it from a ...